Edesa Biotech logo

Edesa Biotech Share Price (NASDAQ: EDSA)

$2.32

-0.07

(-2.93%)

Last updated on

Check the interactive Edesa Biotech Stock chart to analyse performance

Edesa Biotech Inc Key Stats

Check Edesa Biotech key stats like market cap, P/E ratio, EPS, Dividend Yield, and more.

Previous Close
$2.39
Open
$2.31
Market Capitalization
$16.9M
Today's Volume
$51.9K
Revenue TTM
$500.0
EBITDA
$-6.4M
Earnings Per Share (EPS)
$-1.24
Profit Margin
0.0%
Quarterly Earnings Growth YOY
0.0%
Return On Equity TTM
-69.64%

Stock Returns calculator for Edesa Biotech Stock including INR - Dollar returns

The Edesa Biotech stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

*Dollar Return is the profit earned when the US dollar rises in value compared to the Indian rupee.

Investment Value

₹1,00,000

  • 1Y

  • 3Y

  • 5Y

  • 7Y

  • 10Y

Edesa Biotech investment value today

Current value as on today

₹59,238

Returns

₹40,762

(-40.76%)

Returns from Edesa Biotech Stock

₹46,047 (-46.05%)

Dollar Returns*

₹5,284 (+5.28%)

Indian investors sentiment towards Edesa Biotech Stock

-25%

Period: Jul 31, 2025 to Aug 30, 2025. Change in 30 Days versus previous period

Search interest for Edesa Biotech Stock from India on INDmoney has decreased by -25% in the last 30 days, reflecting a downward trend in search activity.

Global Institutional Holdings in Edesa Biotech Inc

  • Name

    Holdings %

  • Velan Capital Investment Management LP

    9.78%

  • Rubric Capital Management LP

    9.78%

  • Nantahala Capital Management, LLC

    8.89%

  • Commonwealth Equity Services Inc

    0.71%

  • Geode Capital Management, LLC

    0.41%

  • Citadel Advisors Llc

    0.24%

Analyst Recommendation on Edesa Biotech Stock

Rating
Trend

Buy

    87%Buy

    12%Hold

    0%Sell

Based on 8 Wall street analysts offering stock ratings for Edesa Biotech(by analysts ranked 0 to 5 stars)

Edesa Biotech Share Price Target

What analysts predicted

Upside of 345.4%

Target:

$10.33

Current:

$2.32

Edesa Biotech share price target is $10.33, a slight Upside of 345.4% compared to current price of $2.32 as per analysts' prediction.

Edesa Biotech Stock Insights

  • Price Movement

    In the last 1 year, EDSA stock has moved down by -46.9%
  • EDSA vs ALNY (1 yr)

    In the last 1 year, Alnylam Pharmaceuticals, Inc. has given 69.9% return, outperforming this stock by 116.8%
  • EDSA vs ALNY (3 yr)

    In the last 3 years, Alnylam Pharmaceuticals, Inc. has given 116.0% return, outperforming this stock by 197.8%

Edesa Biotech Technicals Summary

Sell

Neutral

Buy

Edesa Biotech is currently not in a favorable trading position ( SELL ) according to technical analysis indicators.

Edesa Biotech Inc Vs Peers

Returns
Ratio's
Overview
Company Name1 Month6 Month1 Year3 Years5 Years
Edesa Biotech Inc logo
6.22%
16.02%
-44.42%
-81.03%
-96.22%
Regeneron Pharmaceuticals, Inc. logo
6.48%
-15.2%
-50.31%
-3.3%
-2.01%
Beone Medicines Ltd logo
2.49%
24.81%
62.78%
79.11%
29.69%
Vertex Pharmaceuticals Incorporated logo
-14.45%
-19.13%
-17.84%
34.68%
41.87%
Alnylam Pharmaceuticals, Inc. logo
13.79%
83.28%
75.87%
111.28%
242.25%

About Edesa Biotech Inc

Edesa Biotech, Inc., a clinical-stage biopharmaceutical company, engages in the research and development, manufacture, and commercialization of pharmaceutical products for inflammatory and immune-related diseases. Its lead product candidates are EB05, a monoclonal antibody, which is in Phase 3 clinical study for the treatment of acute respiratory distress syndrome in Covid-19 patients; and EB01, a topical vanishing cream containing non-steroidal anti-inflammatory compound that has completed Phase 3 clinical study to treat chronic allergic contact dermatitis. The company develops EB07, a monoclonal antibody, which is in Phase 2 clinical study for the treatment of pulmonary fibrosis; and EB06, an anti- chemokine ligand 10 (CXCL10) monoclonal antibody in vitiligo. It has a collaboration agreement with NovImmune SA to develop monoclonal antibodies targeting products containing toll-like receptor 4 and CXCL10 for therapeutic, prophylactic, and diagnostic applications in humans and animals; and Yissum Research Development Company for the development of products for therapeutic, prophylactic, and diagnostic uses in topical dermal and anorectal applications, as well as for the use in dermatologic and gastrointestinal conditions. The company was founded in 2015 and is headquartered in Markham, Canada.
Organization
Edesa Biotech
Employees
16
CEO
Dr. Pardeep Nijhawan FRCPC, M.D.
Industry
Biotechnology

Key Management of Edesa Biotech Inc

NameTitle
Dr. Pardeep Nijhawan FRCPC, M.D.
CEO, Company Secretary & Director
Dr. Michael J. Brooks M.B.A., Ph.D.
President
Mr. Peter John Weiler M.B.A, M.Sc.
Chief Financial Officer

Important FAQs about investing in EDSA Stock from India :

What is Edesa Biotech share price today?

Edesa Biotech share price today is $2.32 as on at the close of the market. Edesa Biotech share today touched a day high of {{1_rba_end}} and a low of {{1_rba_st}}.

What is the 52 week high and 52 week low for Edesa Biotech share?

Edesa Biotech share touched a 52 week high of {{rba_end}} and a 52 week low of {{rba_st}}. Edesa Biotech stock price today i.e. is closed at $2.32, lower by 53.6% versus the 52 week high.

How to invest in Edesa Biotech Stock (EDSA) from India?

  1. Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
  2. Step 2: Search for Edesa Biotech on INDmoney app. Click on Buy button. You can invest as low as $1.5 in Edesa Biotech Shares that will get you 0.6466 shares as per Edesa Biotech share price of $2.32 per share as on August 30, 2025 at 12:33 am IST.

What is the minimum amount required to buy Edesa Biotech Stock (EDSA) from India?

Indian investors can start investing in Edesa Biotech (EDSA) shares with as little as ₹88.286 or $1 (as of August 31, 2025) using the INDmoney app.
For example: If you want to invest $10 or ₹882.86 in Edesa Biotech stock (as per the Rupee-Dollar exchange rate as on August 31, 2025). Based on Edesa Biotech share’s latest price of $2.32 as on August 30, 2025 at 12:33 am IST, you will get 4.3103 shares of Edesa Biotech. Learn more about fractional shares .

What are the returns that Edesa Biotech has given to Indian investors in the last 5 years?

Edesa Biotech stock has given -96.22% share price returns and 20.51% dollar appreciation to an Indian investor in the last 5 years.
Read more about How do Currency Exchange Rates impact your returns on US Stock Investments?